- Investing Ideas
- /
- German Pharmaceuticals & Biotech Financially Fit Penny Stocks
German Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
2
0 new
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
2 companies
Heidelberg Pharma
Market Cap: €137.0m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.
HPHA
€2.94
7D
-16.0%
1Y
22.0%
PExA
Market Cap: €8.9m
Develops and commercializes diagnostic products in various respiratory diseases.
FA0
€0.011
7D
-8.0%
1Y
-59.8%